Serum transforming growth factor-β levels in patients with diabetic retinopathy

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 33, Issue 7, 2013, Pages 990-992

  Luo, Da Wei ^a   Zheng, Zhi ^a   Liu, Kun ^a   Zhu, Bi Jun ^a   Xia, Xin ^a   Xu, Xun ^a   Zou, Hai Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; Proliferative diabetic retinopathy; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL;

EID: 84883325559     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1674-8115.2013.07.019     Document Type: Article

References (7)

1. Xu X, Li ZP, Luo D, et al. Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: a factor in diabetic retinopathy [J]. Graefes Arch Clin Exp Ophthalmol, 2003, 241(1): 56-62.
2. 2009, 27(12): 1165-1168.
3. Luo D, Fan Y, Xu X. The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats [J]. Bioorg Med Chem Lett, 2012, 22(13): 4386-4390.
4. 2012, 41(4): 303-306.
5. 1 in the retinas of rats with diabetes [J]. Diabetes Res Clin Pract, 2012, 98(3): 474-480.
6. Grigsby J, Betts B, Vidro-Kotchan E, et al. A possible role of acrolein in diabetic retinopathy: involvement of a VEGF/TGFβ signaling pathway of the retinal pigment epithelium in hyperglycemia [J]. Curr Eye Res, 2012, 37(11): 1045-1053.
7. Zorena K, Malinowska E, Raczyńska D, et al. Serum concentrations of transforming growth factor-Beta 1 in predicting the occurrence of diabetic retinopathy in juvenile patients with type 1 diabetes mellitus [J]. J Diabetes Res, 2013, 2013: 614908.